NRX Pharmaceuticals's market cap is currently $38.47M. The company's EPS TTM is $-2.153; its P/E ratio is ―; NRX Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -5.00K	$ -4.00K	$ -2.00K	$ -907.41K	$ 0.00
Operating Income	$ -27.59M	$ -44.40M	$ -115.80M	$ -51.39M	-
EBITDA	$ -30.02M	$ -39.75M	$ -93.04M	$ -51.72M	$ -713.19K
Net Income	$ -30.15M	$ -35.23M	$ -71.72M	$ -12.35M	$ 408.43K
Balance Sheet
Cash & Short-Term Investments	$ 4.59M	$ 20.05M	$ 27.61M	$ 1.86M	$ 6.00
Total Assets	$ 7.32M	$ 25.82M	$ 32.73M	$ 2.94M	$ 32.07M
Total Debt	$ 9.16M	$ 10.53M	$ 518.00K	$ 797.00K	$ 1.95M
Net Debt	$ 4.57M	$ -9.53M	$ -27.09M	$ -1.06M	$ 1.95M
Total Liabilities	$ 19.05M	$ 18.41M	$ 11.92M	$ 46.71M	$ 2.57M
Stockholders' Equity	$ -11.73M	$ 7.41M	$ 20.81M	$ -43.77M	$ 29.50M
Cash Flow
Free Cash Flow	$ -21.66M	$ -39.77M	$ -37.71M	$ -2.27M	-
Operating Cash Flow	$ -21.66M	$ -39.76M	$ -37.70M	$ -2.27M	$ -792.73K
Investing Cash Flow	$ -3.00K	$ -10.00K	$ -7.00K	$ -2.00K	$ 40.25M
Financing Cash Flow	$ 6.20M	$ 32.21M	$ 63.46M	$ 3.25M	$ -39.46M

Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

Income Statement >

NRX Pharmaceuticals Debt to Assets

Balance Sheet >

NRX Pharmaceuticals Cash Flow

Cash Flow >

NRX Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing